£33m to digitise speciality and commercial insurance using broking and underwriting platform
This article covers Artificial Labs, a London-based insurtech startup that has raised £33m in a series B funding round to accelerate adoption of its digital broking and underwriting platform. The funding is intended to support growth, a planned US expansion in 2026 and deeper engagement with brokers and carriers in the London Market, targeting efficiency gains in the specialty and commercial insurance markets.
Artificial Labs has raised £33 million in a series B funding round to accelerate adoption of its digital broking and underwriting platform across the specialty and commercial insurance markets. The London-based insurtech startup says the funding will support growth, a planned US expansion in 2026 and efforts to deepen its presence in the London Market.
Why it matters
Commercial and specialty insurance remain heavily paper‑ and process‑dependent, especially for complex risk placements. Artificial Labs targets those inefficiencies with software intended to speed trading between brokers and carriers. If the platform delivers as claimed, it could reduce friction for large, multi‑party transactions that have been slow to digitise, with potential efficiency gains across underwriting, placement and post‑bind workflows.
Inside the product
Artificial Labs has built a platform aimed at brokers and carriers, positioning itself as middleware to modernise how risks are quoted, placed and underwritten. The company frames its product as addressing "structural efficiency problems" in commercial and specialty lines — areas where bespoke contract terms and multiple stakeholders make standardisation difficult.
The announcement notes the product supports both broking and carrier workflows and is targeted at large brokers and carriers operating in the London Market and globally. Artificial Labs plans to increase headcount substantially over the next 12 months and to enter the US market in 2026 to serve complex specialty placements there.
Who are the investors?
The round was led by CommerzVentures and included participation from Move Capital Fund I, Augmentum Fintech, 6 Degrees Capital, FOM and TrueSight Ventures.
The investors cited the opportunity to modernise long‑standing industry processes and praised the founding team’s insurance domain expertise combined with engineering capability as reasons for backing the business.
In the announcement, Heiko Schwender, Managing Partner at CommerzVentures, said:
We are thrilled to support Artificial as they extend their leadership globally. We have been backing next generation technology businesses for more than a decade. Artificial’s platform addresses a real, structural problem that has constrained efficiency in commercial and specialty insurance for decades. The team’s combination of deep insurance domain expertise and world class engineering is rare, and it uniquely positions them to redefine this market.
In the announcement, Hervé Malausséna, Founding Partner at Move Capital, said:
Artificial benefits from a rare blend of deep insurance expertise, strong client relationships and highly innovative technology. The company is ideally positioned to address bottleneck challenges for specialty risk placement players globally, which reflects Move Capital’s conviction in platforms that turn domain expertise into scalable, data-driven operational execution.
If you're researching potential backers in this space:
- Explore our list of insurtech venture capital firms in the UK
- Browse our directory of insurtech angel investors in the UK
Founder perspective
Co‑founders framed the round as a capacity and confidence play to keep pace with large clients and scale the business.
In the announcement, David King, Co‑founder at Artificial Labs, said:
This round gives us the room to grow with confidence. The investment allows us to scale in a way that keeps pace with our clients. We have the teams, the technology, and the stability to support the largest brokers and carriers as they modernise how they operate.
In the announcement, Johnny Bridges, Co‑founder at Artificial Labs, said:
We have built a platform that solves real problems for insurance. With this investment, we will grow our team, continue to innovate, and ensure that Artificial remains the natural choice for brokers and carriers seeking a smarter way to trade digitally.
The bigger picture
The funding adds to a steady stream of capital flowing into technology that tackles legacy processes in financial services and insurance. For the London Market — a global hub for specialty risk — new digital tooling from startups like Artificial Labs is increasingly touted as a route to maintain competitiveness against US and continental rivals.
The round also signals continued interest from insurtech investors in platforms that promise to convert domain expertise into scalable, data‑driven workflows. Artificial Labs’ planned US expansion will be one to watch: success there would demonstrate the portability of its approach beyond the nuances of the London Market.
This deal underlines how UK insurtech innovation is evolving from point solutions to broader transactional infrastructure — a theme likely to shape investor activity across Europe over the next few years.
They've invested in Artificial Labs
Get to know these insurtech investors
| Investor | Sector | Stage | Activity | Team | Connect |
|---|---|---|---|---|---|
 CommerzVentures | 4 investments investments | more info | |||
 Move Capital Fund I | 1 investment investment | more info | |||
 Augmentum Fintech | 14 investments investments | 4 contacts contacts | |||
 6 Degrees Capital | 2 investments investments | 8 contacts contacts | |||
 TrueSight Ventures | 2 investments investments | 2 contacts contacts |
Click here for a full list of 7,526+ startup investors in the UK